Mortality in homeless people enrolled in the French housing first randomized controlled trial: a secondary outcome analysis of predictors and causes of death

Table 3 Death differences in mental and physical health comorbidities and self-reported health status and quality of life between the 34 deceased homeless and the 669 alive homeless ^a population with schizophrenia (SZ) or bipolar disorders (BD)

Variables	*Univariate Cox analysis* HR *(95%CI)*	p	*Multivariate Cox analysis* HR *(95%CI)*	p
Group (HF vs. TAU)	0.58 (0.28–1.19)	0.141	0.49 (0.24–1.01)	0.054^b
Gender (Men vs. Women)	0.89 (0.35–2.31)	0.816
Age	1.02 (0.99–1.05)	0.250
Education, (Bac vs. <bac)	0.99 (0.95–1.05)	0.976
Housing status, (Abs. vs. Prec.)	1.09 (0.53–2.23)	0.821
Lifetime duration of homelessness	0.85 (0.41–1.78)	0.662
Mental diagnosis (SZ vs. BD)	1.26 (0.62–2.54)	0.521
CGI Score	1.03 (0.78–1.35)	0.854
MCAS score	0.97 (0.92–1.01)	0.164
PCS SF-36 score	0.97 (0.95–1.01)	0.084
MCS SF-36 score	0.99 (0.95–1.01)	0.922
Violent victimization	1.13 (0.55–2.20)	0.739
Nonviolent victimization	2.02 (0.96–4.24)	0.062
Alcohol dependence	1.50 (0.61–3.70)	0.376
Substance dependence	1.02 (0.40–2.59)	0.965
Hospitalization	1.28 (0.95–1.73)	0.097
Taking medicines	1.33 (0.58–3.08)	0.499
Medications for Opioid Use Disorder	2.31 (1.08–4.91)	0.030	2.37 (1.11–5.05)	0.025
Psychotropic drugs	0.98 (0.47–2.05)	0.972
Other treatments	0.98 (0.47–2.05)	0.972
−2 Log Likelihood		Block 0	441.742
		Block 1	434.195	0.018

^aAlive at the date of the last follow-up visit or the date of the last news for those who were initially lost to follow-up
^bAfter controlling for all interactions between variable “group” and covariates, none interaction were kept in the final model
Values in bold indicate a statistically significant difference between groups
HF Housing First, TAU Treatment-as-usual, Abs. vs; Pres. Absence or Presence, CGI Clinical Global Impression scale, MCAS Multnomah Community Ability Scale, SZ schizophrenia, BD bipolar disorder, SF-36 Medical Outcomes Study 36-iIem Short-Form Health Survey, PCS physical composite score, MCS mental composite score, MOUD Medications for Opioid Use Disorder

ISSN: 1471-2458